Comparison

OTR-AC vs LGD-4033

Ostarine acetate's steady delivery vs LGD-4033's raw mass-building potency.

Effectiveness Profile

OTR-AC
LGD-4033

At a Glance

 OTR-ACLGD-4033
TypeSARMSARM
Legal statusResearchResearch
Half-life36–48 hours (community estimate; no published PK)24–36 hours
Preferred routeOralOral
Dose frequencyonce-dailyonce-daily
Beginner dose5–10 mg5–5 mg
Intermediate dose10–15 mg5–10 mg
Advanced dose15–20 mg10–20 mg
Cycle length6–12 wks6–8 wks
Bioavailability80%90%
Time to peak3h2h
Active duration36h24h
StorageRoom temperature, dry, dark; refrigerate liquid suspensionsRoom temperature, dry, away from light
PCT requiredYesYes
Ancillaries requiredYesYes
Safe for womenYesNo
Anabolic / androgenic90 / 5500 / 1

Verdict

OTR-AC wins for: Ultra-stable blood levels, lowest suppression risk in the SARM class, and best-in-class muscle preservation during a deficit or injury recovery. Ideal for recomp or conservative users prioritizing safety, joint relief, or healing.

LGD-4033 wins for: Outright anabolic power, sheer lean-mass gain per mg, and proven clinical backing for muscle-building in both clinical and recreational settings. The go-to for bulking, hard cuts, or when chasing maximum physique change—especially when suppression is managed proactively.

Pick A or B?

Pick OTR-AC if:

  • Joint or tendon support is a primary research goal and minimizing suppression is essential.
  • Recomp, muscle preservation in a calorie deficit, or maintenance after injury are main objectives.
  • Once-daily dosing and highly stable serum levels are preferred for protocol simplicity.
  • Literature-backed muscle sparing (ostarine) is prioritized over pure mass gains.
  • Protocols include stacking with MK-677 or cardarine for a balanced recomp effect without major risk.

Pick LGD-4033 if:

  • Maximizing lean-mass gain per cycle is the primary endpoint, even with greater suppression risk.
  • Protocols involve bulking, aggressive cuts with enhanced strength retention, or bridging between AAS runs.
  • A stronger anabolic ceiling or larger physique shift is required—e.g., for hard gainers or advanced users.
  • Community experience and dosing ranges are already well-documented and easy to replicate.
  • Shorter half-life allows flexible dosing windows and rapid intervention in case of side effects.